Last reviewed · How we verify

NCT05108493

Efficacy of Dry Needling in the Treatment of Lateral Epicondylitis

Completed NA Last updated 31 January 2023
What this trial tests

NA trial testing Dry needling in Tennis Elbow in 111 participants. Completed in 1 December 2022.

Timeline
1 December 2021
Primary endpoint
1 December 2022
1 December 2022

Quick facts

Lead sponsorBozyaka Training and Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment111
Start date1 December 2021
Primary completion1 December 2022
Estimated completion1 December 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bozyaka Training and Research Hospital

Who can join

Adults 18 to 65, any sex, with Tennis Elbow or Dry Needling. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Lateral epicondylitis is painful tendinosis of the main extensor tendon that occurs at the fibro-osseous junction of the outer elbow region. Histopathological samples in patients with chronic lateral epicondylitis show that there is angiofibroblastic degeneration and failure in the normal tendon repair process rather than acute inflammation in this region. It has begun to be accepted that the main factor in lateral epicondylitis is not the inflammatory events but the degenerative process. There are many treatment methods that trigger structural healing in tendinopathies. In this study, the investigators aimed to evaluate the effect of the dry needling method of the lateral epicondyle region.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dry needling

Trials testing the same drug.

Other recruiting trials for Tennis Elbow

Currently open trials in the same condition.

Other Bozyaka Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05108493.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing